Trafalgar International, Inc. (GCAN)
OTCMKTS · Delayed Price · Currency is USD
0.2020
0.00 (0.00%)
At close: Aug 24, 2026
Trafalgar International Employees
Trafalgar International had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
$879,660
Market Cap
200.87K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - |
| Dec 31, 2024 | 1 | 0 | - |
| Dec 31, 2023 | 1 | 0 | - |
| Dec 31, 2022 | 1 | 0 | - |
| Dec 31, 2021 | 1 | -1 | -50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Trafalgar International News
- 7 days ago - Trafalgar International Launches U.S. Public Company Platform for Financial Services and Strategic Investment - PRNewsWire
- 9 months ago - GCANRx Announces Relisting To OTCQB Market Tier - GlobeNewsWire
- 1 year ago - GCANRx Announces Uplisting to New Market Tier - GlobeNewsWire
- 1 year ago - GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing - GlobeNewsWire
- 2 years ago - GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy - GlobeNewsWire
- 3 years ago - GCANRx Featured in American Journal of Endocannabinoid Medicine - GlobeNewsWire
- 3 years ago - GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders - GlobeNewsWire
- 4 years ago - GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders - GlobeNewsWire